This study was done to mask the bitter taste of ondansetron HCl using complexing agent, a polacrilex resin: Tulsion 335 and subsequently forming mouth dissolving tablet using superdisintegrants: Croscarmellose sodium and sodium starch glycollate. A preliminary screening was done. Batch process, a most preferential method for drug loading with ion exchange resins was selected. The process was optimized for drug: resin ratio to get maximum drug loading. A ratio of drug: resin at 1:3 was selected. Taste evaluation was carried out by selecting volunteers. Drug resin complex (DRC) was evaluated for drug release. The resultant DRC was formulated by direct compression into mouth dissolving tablet using microcrystalline cellulose PH 102, as diluent and croscarmalose sodium and sodium starch glycolate as superdisintegrants and aspartame was used as sweetening agent to enhance palatability. Thirteen formulations were developed by using superdisintegrants: croscarmellose sodium and sodium starch glycolate. Concentration of superdisintegrants ranged from 0.75-9.24 %. The formulated tablet had satisfactory disintegration time and dissolution profile. Optimization was carried out using central composite design. The disintegration and dissolution times were tallied with marketed ondansetron HCl tablets. From the results, it was deduced that the most effective concentration for desired disintegration was of croscarmellose sodium and sodium starch glycollate respectively at concentration above 5%. Therefore, it can be concluded that the intensely bitter taste of ondansetron HCl can be masked by using tulsion 335 and mouth dissolving ondansetron HCl can be successfully prepared by adding aforementioned superdisintegrants. This sort of mouth dissolving ondansetron HCl can be used in controlling vomiting in paediatric and geriatric patients and also for pregnancy induced vomiting. Key Words: Ondansetron HCl, Complexation, taste masking, ODT, mouth dissolving tablet INTRODUCTION Research over the past few years has revealed that ion exchange resins are equally suitable for drug delivery technologies, including controlled release, site-specific fast dissolving, iontophoretically-assisted transdermal, nasal, topical, and taste masked systems [1]. Many research have been conducted on taste masking and formulation of orodispersable Ondansetron HCl. Taste masking were performed by using eudragit EPO, indion 204, ethyl cellulose in different ratios. These were then compressed into tablets by direct compression method with using different superdisintegrants like croscarmellose sodium, crospovidone sodium starch glycolate and glycine-chitosan mixture in different concentrations [ 2, 3, 4] . Conventional tablets are intended to be swallowed whole and desired to disintegrate, release the medicaments for dissolution and providing therapeutic efficacy rapidly in the gastrointestinal tract. As disintegration plays a crucial role, so for development of solid orals, formulators are fascinating towards selection of proper disintegrants/ superdisintegrants [3] . Because the disintegration time is related to other formulation variables, a balance has to be maintained between shortening the disintegration time and other tablet properties. FDT formulation that would require fewer excipients than the drug itself would be a breakthrough. The proper choice of a disintegrant or a superdisintegrant and its consistent performance are of critical importance to the formulation development of such tablets. Drug release from a solid dosage form can be enhanced by addition of suitable disintegrants. In the formulation superdisintegrants play a key role in determining dissolution of finished drug. Hence type of superdisintegrant, concentration and mode of addition is having greater impact on dissolution profile of drug [4] . The present study is aimed to mask the bitter taste of ondansetron HCl and determine the effect of concentration and mode of addition of superdisintegrants on release.
MATERIALS AND METHODS
Polacrilex resin (Tulsion 335) was the gift sample from CTL Pharmaceuticals, Bhaktapur and Ondansetron HCL was gift sample from Lomus Pharmaceutical Pvt. Ltd, Gothatar VDC, Kathmandu, Nepal. Croscarmellose sodium, sodium starch glycollate, mannitol, MCCPH 102, magnesium stearate, , mix fruit flavour, were received as gift samples from Nova Genetica Pharmaceutical Pvt. Ltd, Naubise VDC, Dhading , Nepal. Other reagents were of analytical grade and were made available in the Kathmandu University laboratory, Dhulikhel. Preparation of drug resin complex [5] Five grams of Tulsion 335 (Polacrilex) swollen for 90 minutes in 200 ml of deionized water was added to 5 g of Ondansetron HCl and then stirred for 90 minutes, filtered through Whatmann No. 41. The residue was washed with 100 ml of deionized water and dried. Optimization of various parameters for maximum drug loading [6, 7] Drug loading process was optimized for maximum drug loading considering effect of activation, drug: resin ratio and pH as parameters.
Resin Activation
Five g of Tulsion 335, placed on a Whatman filter paper in a funnel, was washed with deionized water and subsequently with 0.1 N HCl (100 ml) or 0.1 N NaOH or combined treatment of 0.1 N HCl and 0.1 N NaOH.
Optimization of drug: resin ratio and pH
Five g of Ondansetron HCl was added to each of the beakers containing 5, 10 and 15 g of resin swelled in 300 ml of deionized water. The mixture was stirred for 90 min. DRC was collected by filtration, washed with 100 ml of deionized water and evaluated for drug content. pH was optimized by preparing DRC using 5 g each of Ondansetron and 15 g resin in 200 ml deionized water and adjusting pH with 1.2, 2, 3, 4, 5, 6, 7, and 8 using standard solutions of hydrochloride and sodium hydroxide. Loading efficiency was determined at these conditions. Estimation of drug content in DRC 32.53 mg of DRC was stirred with 100 ml of 0.1 N HCl for 60 min so as to release the entire drug from DRC. The mixture was filtered diluted and content determined 310 nm using UV visible spectrophotometer. In vitro dissolution studies DRC equivalent to 8 mg of Ondansetron HCl was subjected to USP Type I dissolution at 37±2°C at 50 rpm speed. 500 ml of 0.1 N HCl was used as dissolution medium. DRC equivalent to 8 mg of Ondansetron was placed in basket surrounded by muslin cloth. Aliquot equal to 5 ml was withdrawn after every 2 min. intervals (For total 10 min.) and amount of Ondansetron released from DRC determined at 310 nm [8] .
Gustatory Sensation Test
Microparticles containing 8 mg of DRC was dispersed in 25 ml of water for 15 seconds. Then, each volunteer (age 18-22) held about 5 ml of the dispersion in the mouth for 30 seconds. Bitterness level was recorded against pure drug using a numerical scale from 0 to 4 (0: no bitterness, 1: threshold bitterness, 2: bitter, 3: moderate bitterness, and 4: strong bitterness) instantly and then after 30-150 sec. Rinsing the mouth by distilled water and a gap of 30 minutes were applied between successive tests. Based on the opinion of the volunteers, threshold bitterness concentration of DRC was judged [9] . Pre compression parameter studies The DRCs evaluated for bulk density, tap density, compressibility, angle of repose and flow rate [10] Batches of fast dissolving tablet prepared were A 1 to A 13 . The formulation A 0 was with taste masked granules without superdisintegrants.
Evaluation of Tablets for post compression parameters [11]
Tablets were evaluated for their physicochemical parameters such as thickness and diameter, weight variation, hardness, friability, assay, disintegration time, wetting time and In Vitro dissolution.
Drug content Determination Preparation of standard
Ondansetron HCl reference standard (400 µg/ml ) was weighed accurately. The drug was dissolved in 0.1N HCl and volume was made upto 100 ml with the same solvent. Then, 1 ml was diluted to 50 ml with the same solvent.
Preparation of sample
Accurately a quantity of the tablet powder (150 mg) from 20 crushed tablets equivalent to 8 mg of the ondansetron HCl was weighed from three different places and then transferred in three 100 ml volumetric flasks. Then, the samples were dissolved in 0.1N HCl and volume was made up to 100 ml using same solvent. The samples were sonicated for about 15 minutes and were then filtered through whatman filter paper. Then the filtrate 5 ml was diluted to 50 ml by using 0.1N HCl. The absorbance of this final solution and standard ondansetron HCl solution were compared at wavelength 310 nm using 0.1N HCl as a blank using UV-visible spectrophometer. In vitro release study [8] In vitro drug release was studied using medium 0.1 N HCl, Volume: 500ml, Type I apparatus at 50 rpm and aliquots withdrawn at 10 mins interval.
Drug
min to 60 min and taste was found to be slightly masked but percentage drug loading increased from 30.15% ± 1.04% for 60 min [59] . In the same experiment activation with drug polymer ratio 1:5 swelling for 30 minutes and activation for 240 minutes resulted 61.4% for acid, 45.80% for alkali and 28.69% of drug loading for acid-alkali activation [12] . Optimization of pH 
